These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13330473)

  • 1. [Oral therapy of diabetes mellitus by N-tolyl-sulfonyl-N'-butyl urea (D 860); clinical and experimental studies].
    BANDER A; CREUTZFELDT W; DORFMULLER T; EHRHART H; MARX R; MASKE H; MEIER W; MOHNIKE G; PFEIFFER EF; SCHLAGINTWEIT S; SCHOFFLING K; SCHOLZ J; SEIDLER I; STEIGERWALD H; STICH W; STOTTER G; ULRICH H
    Dtsch Med Wochenschr; 1956 May; 81(21):823-46; contd. PubMed ID: 13330473
    [No Abstract]   [Full Text] [Related]  

  • 2. [N-tolyl-sulfonyl-N'-butyl urea in the ambulatory therapy of diabetes].
    FRANCHI G
    Gazz Med Ital; 1957 Jan; 116(1):1-12. PubMed ID: 13427964
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary note on the oral treatment of diabetes by N-sulfonyl-p-methylbenzene-N'-n-butyl urea or D 860, a product free of antibacterial action].
    MOREAU R; DEUIL R; SARRAZIN A; DE TRAVERSE PM; MARTINET M
    Presse Med (1893); 1956 Jul; 64(54):1261-4. PubMed ID: 13350129
    [No Abstract]   [Full Text] [Related]  

  • 4. [Oral treatment of diabetes mellitus with N-4-methyl-benzolsulfonyl-N'-butyl-urea (D-860); clinical and experimental research].
    Dtsch Med Wochenschr; 1956 Jun; 81(22):887-960; concl. PubMed ID: 13344014
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral treatment of diabetes mellitus with a sulfonamide derivative; N1-sulfanilyn-N2-n-butyl carbamide].
    ANGELI G; TEDESCHI G
    Minerva Med; 1956 Jun; 47(50):1968-75. PubMed ID: 13348337
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral therapy of diabetes mellitus with invenol].
    BLOCH J; LENHARDT A
    Wien Med Wochenschr; 1956 Jul; 106(27):594-8. PubMed ID: 13353170
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results and clinical aspects of new oral treatment of diabetes mellitus with N-butylsulfanilylurea BZ-55].
    INTROZZI P; MARIGO S
    Minerva Med; 1956 Jun; 47(50):1959-66. PubMed ID: 13348335
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peroral treatment of diabetes. II. Oral treatment of diabetes mellitus with D 860].
    KUHLMANN F
    Med Klin; 1956 Nov; 51(45):1919-21. PubMed ID: 13386836
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral treatment of diabetes.
    FISHER AM
    Can J Public Health; 1956 Jul; 47(7):296-7. PubMed ID: 13343054
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trial of oral therapy in diabetes with D 860].
    DE TRAVERSE PM; DEUIL R; MOREAU R; SARRAZIN A
    Bull Mem Soc Med Hop Paris; 1956; 72(26):788-99. PubMed ID: 13383373
    [No Abstract]   [Full Text] [Related]  

  • 11. [Examination of steroids in therapy with N'-sulfanilyl-N2-N-butylcarbamid (nadisan)].
    RAUSCH-STROOMANN JG; SAUER H
    Klin Wochenschr; 1956 Jul; 34(25-26):707-8. PubMed ID: 13347046
    [No Abstract]   [Full Text] [Related]  

  • 12. BZ-55 (CARBUTAMIDE): experimental and clinical studies of an oral antidiabetic agent.
    Can Med Assoc J; 1956 Jun; 74(12):957-98. PubMed ID: 13329939
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trial therapy of diabetes mellitus with BZ 55].
    BOULIN R
    Presse Med (1893); 1956 Apr; 64(28):643-5. PubMed ID: 13335854
    [No Abstract]   [Full Text] [Related]  

  • 14. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
    DIENGOTT D; DOLGER H; MIRSKY IA
    Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical use of oral sulfonylurea compounds in diabetes mellitus.
    COLWELL AR; COLWELL JA
    Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral therapy of diabetes with sulfanyl urea derivatives].
    OTTO H
    Riforma Med; 1957 May; 71(18):489-93. PubMed ID: 13442483
    [No Abstract]   [Full Text] [Related]  

  • 17. [New possibilities in the therapy of diabetes; critical report on an oral antidiabetic drug].
    STEIGERWALDT F
    Med Monatsschr; 1955 Dec; 9(12):793-5. PubMed ID: 13296832
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of diabetes mellitus with BZ-55.
    METZLER WS
    Can Med Assoc J; 1956 Jun; 74(12):987-8. PubMed ID: 13329952
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of diabetes mellitus with BZ-55.
    CHARLES B
    Can Med Assoc J; 1956 Jun; 74(12):985-7. PubMed ID: 13329951
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of sulphonylurea derivatives in the management of diabetes mellitus; a preliminary report.
    DOWNIE E; BORNSTEIN J; HUDSON B; TAYLOR K
    Med J Aust; 1956 Jun; 43(26):1072-8. PubMed ID: 13347438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.